University of Rochester Medical Center Boosts Diagnostic Accuracy and Workflow Efficiency with Butterfly Network’s Enterprise Ultrasound Solution
Butterfly Network, Inc. (NYSE: BFLY) has published a case study highlighting the successful implementation of its point-of-care ultrasound (POCUS) devices and Compass™ workflow software at the University of Rochester Medical Center (URMC). The deployment resulted in a 116% increase in ultrasound charge capture across the health system. URMC has deployed 862 Butterfly devices across 64 departments and plans to scale to 2,500 devices by 2026.
Key achievements include:
- Nearly 50,000 scanning sessions completed since 2022
- 74% increase in scanning sessions in 2023
- 147% rise in studies uploaded from Butterfly devices
- 1,782% jump in images uploaded from non-Butterfly devices
These results have contributed to earlier diagnoses and improved patient outcomes while reducing emergency visits.
Butterfly Network, Inc. (NYSE: BFLY) ha pubblicato uno studio di caso che evidenzia l'implementazione di successo dei suoi dispositivi di ultrasuoni point-of-care (POCUS) e del software per il flusso di lavoro Compass™ presso il University of Rochester Medical Center (URMC). L'implementazione ha portato a un aumento del 116% nella cattura delle fatture per ultrasuoni in tutto il sistema sanitario. URMC ha distribuito 862 dispositivi Butterfly in 64 reparti e prevede di arrivare a 2.500 dispositivi entro il 2026.
I risultati chiave includono:
- Quasi 50.000 sessioni di scansione completate dal 2022
- Aumento del 74% delle sessioni di scansione nel 2023
- Incremento del 147% nello studio caricato dai dispositivi Butterfly
- Salto del 1.782% nelle immagini caricate da dispositivi non Butterfly
Questi risultati hanno contribuito a diagnosi più precoci e a un miglioramento degli esiti clinici dei pazienti, riducendo nel contempo le visite al pronto soccorso.
Butterfly Network, Inc. (NYSE: BFLY) ha publicado un estudio de caso destacando la exitosa implementación de sus dispositivos de ultrasonido point-of-care (POCUS) y el software de flujo de trabajo Compass™ en el University of Rochester Medical Center (URMC). La implementación resultó en un aumento del 116% en la captura de cargos por ultrasonido en todo el sistema de salud. URMC ha desplegado 862 dispositivos Butterfly en 64 departamentos y planea escalar a 2,500 dispositivos para 2026.
Los logros clave incluyen:
- Casi 50,000 sesiones de escaneo completadas desde 2022
- Aumento del 74% en las sesiones de escaneo en 2023
- Incremento del 147% en estudios subidos desde dispositivos Butterfly
- Aumento del 1,782% en imágenes subidas desde dispositivos no Butterfly
Estos resultados han contribuido a diagnósticos más tempranos y a una mejora en los resultados para los pacientes, reduciendo al mismo tiempo las visitas de emergencia.
버터플라이 네트워크, Inc. (NYSE: BFLY)가 로체스터 대학교 의료 센터(URMC)에서의 포인트 오브 케어 초음파(POCUS) 장치 및 Compass™ 워크플로 소프트웨어의 성공적인 구현을 강조하는 사례 연구를 발표했습니다. 이 배치는 건강 시스템 전반에 걸쳐 116%의 초음파 요금 캡처 증가를 가져왔습니다. URMC는 862개의 버터플라이 장치를 64개 부서에 배포했으며, 2026년까지 2,500개로 확장할 계획입니다.
주요 성과는 다음과 같습니다:
- 2022년 이후 완료된 스캔 세션이 거의 50,000회
- 2023년에 스캔 세션이 74% 증가
- 버터플라이 장치에서 업로드된 연구가 147% 증가
- 비버터플라이 장치에서 업로드된 이미지가 1,782% 증가
이러한 결과는 보다 조기 진단과 개선된 환자 결과에 기여하고 응급 방문을 줄이는 데 도움이 되었습니다.
Butterfly Network, Inc. (NYSE: BFLY) a publié une étude de cas mettant en lumière la mise en œuvre réussie de ses dispositifs d'échographie point-of-care (POCUS) et du logiciel de flux de travail Compass™ au sein du University of Rochester Medical Center (URMC). Cette mise en œuvre a entraîné une augmentation de 116 % de la capture des frais d'échographie dans tout le système de santé. URMC a déployé 862 dispositifs Butterfly dans 64 départements et prévoit de passer à 2 500 dispositifs d'ici 2026.
Les réalisations clés incluent :
- Près de 50 000 sessions de scan complétées depuis 2022
- Augmentation de 74 % des sessions de scan en 2023
- Augmentation de 147 % des études téléchargées depuis les dispositifs Butterfly
- Augmentation de 1 782 % des images téléchargées depuis des dispositifs non Butterfly
Ces résultats ont contribué à des diagnostics plus précoces et à de meilleurs résultats pour les patients tout en réduisant les visites aux urgences.
Die Butterfly Network, Inc. (NYSE: BFLY) hat eine Fallstudie veröffentlicht, die die erfolgreiche Implementierung ihrer Point-of-Care-Ultraschall(POCUS)-Geräte und der Compass™-Workflow-Software am University of Rochester Medical Center (URMC) hervorhebt. Der Einsatz führte zu einem 116%igen Anstieg der Ultraschallgebühren im gesamten Gesundheitswesen. URMC hat 862 Butterfly-Geräte in 64 Abteilungen implementiert und plant, bis 2026 auf 2.500 Geräte zu erweitern.
Zu den wichtigsten Erfolgen gehören:
- Fast 50.000 durchgeführte Scan-Sitzungen seit 2022
- 74% Anstieg der Scan-Sitzungen im Jahr 2023
- 147% Anstieg der von Butterfly-Geräten hochgeladenen Studien
- 1.782% Anstieg der von Nicht-Butterfly-Geräten hochgeladenen Bilder
Diese Ergebnisse haben zu früheren Diagnosen und verbesserten Patientenergebnissen beigetragen und gleichzeitig die Notfallbesuche verringert.
- 116% increase in ultrasound charge capture across URMC health system
- Deployment of 862 Butterfly devices across 64 departments, with plans to scale to 2,500 devices by 2026
- 74% increase in scanning sessions in 2023
- 147% rise in studies uploaded from Butterfly devices
- 1,782% jump in images uploaded from non-Butterfly devices
- Improved patient outcomes through earlier diagnoses
- Reduced emergency visits
- None.
Insights
The implementation of Butterfly Network's POCUS devices and Compass™ software at URMC represents a significant advancement in diagnostic capabilities and workflow efficiency. The 116% increase in ultrasound charge capture is particularly noteworthy, indicating substantial financial benefits for the health system. The 74% increase in scanning sessions and 147% rise in studies uploaded from Butterfly devices demonstrate widespread adoption and integration into clinical practice.
From a clinical perspective, the ability to detect conditions like cholecystitis, abscesses and bladder masses earlier is important for improving patient outcomes. This proactive approach to diagnosis can significantly reduce emergency visits and associated costs. The planned expansion to 2,500 devices by 2026 suggests long-term commitment and potential for even greater impact on patient care and operational efficiency.
The URMC case study presents compelling financial implications for Butterfly Network (NYSE: BFLY). The substantial increase in ultrasound charge capture directly translates to revenue growth for healthcare providers, which could drive demand for Butterfly's products. The planned expansion from 862 to 2,500 devices by 2026 at URMC alone indicates a strong growth trajectory for Butterfly's sales.
Moreover, the 1,782% jump in images uploaded from non-Butterfly devices suggests that Butterfly's Compass™ software has potential as a standalone product, possibly opening up additional revenue streams. The demonstrated ROI and efficiency gains could attract other large healthcare systems, potentially leading to significant market expansion for Butterfly Network. Investors should monitor for similar implementations at other institutions as indicators of broader market adoption.
Butterfly Network's semiconductor-based ultrasound technology represents a significant leap in POCUS capabilities. The integration of their devices with the Compass™ workflow software demonstrates a comprehensive ecosystem approach, which is important for wide-scale adoption in complex healthcare environments. The ability to handle 50,000 scanning sessions generating over 175,000 images indicates robust scalability and reliability of the system.
The interoperability with non-Butterfly devices, as evidenced by the 1,782% increase in images uploaded from such devices, showcases the platform's flexibility and potential for becoming an industry standard. This open approach could be a key differentiator in the competitive medical technology market. The system's ability to improve diagnostic accuracy while enhancing workflow efficiency addresses two critical needs in healthcare technology, positioning Butterfly Network favorably in the rapidly evolving digital health landscape.
-
URMC increased ultrasound charge capture by
116% following system-wide deployment of Butterfly Network devices and Compass™ workflow software. - URMC’s implementation results published on September 16, 2024 in the Journal of Clinical Imaging Science.
URMC Primary Care training on Butterfly devices. June 2022 (Photo: Business Wire)
In early 2021, URMC partnered with Butterfly to launch an enterprise-wide ultrasound program designed to improve access to imaging, enhance clinical workflows, and drive value for both patients and providers. To date, URMC has deployed 862 Butterfly devices across 64 academic departments and clinical programs, integrated with Butterfly’s Compass™ workflow software. URMC plans to scale the program to 2,500 devices by 2026. This innovative implementation has resulted in a
Since 2022, nearly 50,000 scanning sessions have been completed, generating over 175,000 images and 15,524 finalized reports. This growth has fueled a
“Our phased deployment of Butterfly devices and Compass software has yielded impressive clinical and administrative results at URMC to date. URMC is proud to be at the forefront of the wide-scale deployment of innovative point-of-care ultrasound technology, and we believe it shows promise as the right care model for the medical community at large,” commented Michael F. Rotondo, MD, Chief Executive Officer of the University of Rochester Medical Faculty Group, Senior Vice President of URMC.
“I’m inspired by Dr. Rotondo’s visionary leadership in driving the system-wide deployment of point-of-care ultrasound across URMC. Patients are receiving care earlier, doctors are empowered to make a greater impact, and care is becoming more efficient – proving a compelling return on investment,” said Joseph DeVivo, president, CEO, and board chairman of Butterfly Network. “Health system leaders are recognizing the power of POCUS as a comprehensive solution. Thousands of studies confirm early diagnoses across venues annually, yet many go unrecorded and unreimbursed, resulting in millions of dollars in unbilled ultrasound scans. Individual providers are already onboard; tens of thousands have purchased their own Butterfly devices knowing they improve patient care. Now it’s time for health system C-suites to work with those doctors to build an enterprise-wide POCUS program. This means committing to education, deploying Butterfly’s Compass Software, and integrating Butterfly iQ3 across their institution to deliver state-of-the-art early diagnosis and unlock these strong clinical and financial results.”
To read the full case study visit: https://butterflynetwork.com/case-studies-urmc. For more information on Butterfly Network, visit www.butterflynetwork.com.
For more information on the University of Rochester Medical Center, visit https://www.urmc.rochester.edu.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second-generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of
View source version on businesswire.com: https://www.businesswire.com/news/home/20240917669860/en/
Butterfly Media:
Liz Learned
Head of Corporate Communications, Butterfly
media@butterflynetwork.com
Butterfly Investors:
Heather Getz
Chief Financial and Operations Officers, Butterfly
investors@butterflynetwork.com
Source: Butterfly Network, Inc.
FAQ
What was the percentage increase in ultrasound charge capture at URMC after implementing Butterfly Network's solution?
How many Butterfly devices has URMC deployed, and what are their future plans?
What percentage increase in scanning sessions did URMC see in 2023 using Butterfly Network's devices?
How has the implementation of Butterfly Network's solution (BFLY) affected patient outcomes at URMC?
